Clinical Trial Update: PRE-I-SPY Phase I/Ib Oncology Platform Program [Phase 1]

View source ↗

Summary

Pre-I-SPY Phase I/Ib oncology platform program update with Phase 1 recruitment ongoing across multiple breast cancer indications, including HER2-positive and ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: QuantumLeap Healthcare Collaborative | Conditions: HER2-positive Breast Cancer, Metastatic Cancer | Phase 1 | Status: RECRUITING